Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VTVTthis companyvTv Therapeutics Inc.	$21.10	-12.5×	5.23×	0×	-7.98×	-50.1%	0.0%	0.0%	0.0%	-41.9%	-39.4%	-7.5%	0×	2.86×	-5,468×	13.54×	0.0%	2	1.49	1	C-
CRVOCervoMed Inc.	$1.40	-2.65×	3.92×	0×	-2.34×	-43.0%	0.0%	0.0%	0.0%	-148.0%	-151.0%	-32.8%	0×	0.31×	0×	4.84×	0.0%	1	-7.98	2	C
FBIOFortress Biotech, Inc.	$1.99	-54.3×	2.05×	1.61×	-4.81×	-576.5%	66.9%	-111.0%	10.8%	13.7%	-50.0%	-64.4%	1.49×	0.25×	-8.06×	2.49×	0.7%	6	0.13	4	A-
GANXGain Therapeutics, Inc.	$1.11	-5.28×	5.72×	0×	-4.48×	-43.6%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-17.4%	0.04×	1.05×	0×	6.63×	0.0%	3	-6.96	2	C
HOWLWerewolf Therapeutics, Inc.	$1.02	-0.48×	1.18×	0×	0.36×	-0.7%	0.0%	0.0%	0.0%	-245.2%	-173.4%	-206.8%	0.38×	0.9×	-11.5×	1.62×	0.0%	4	-26.27	2	C+
INKTMiNK Therapeutics, Inc.	$10.48	-3.81×	-3.35×	0×	-3.2×	-89.1%	0.0%	0.0%	0.0%	87.8%	-195.5%	-12.4%	-0.36×	0.66×	0×	1.06×	0.0%	2	-26.28	2	C
Peer median	—	-3.81×	2.05×	0×	-3.2×	-43.6%	0.0%	0.0%	0.0%	-108.6%	-151.0%	-32.8%	0.04×	0.66×	0×	2.49×	0.0%	3	-7.98	2	—